Tel. +39 010.51862.1

Piam News

PKU Talks: The expert’s voice

Doctor Rocha: the assessment of the nutritional status of PKU patients and the impact of their diet on the metabolism. PKU TALKS: THE EXPERT’S VOICE is the periodical column on Phenylketonuria, created by Piam in collaboration with major international specialists. Today the interview with Doctor Julio Cesar Rocha, of the Faculdade de Ciências Médicas, Universidade...

Piam Iberia: Italian Pharma on the International Marketplaces

Piam Farmaceutici is starting up a subsidiary in Madrid, Spain. Andrea Maini, Piam’s Managing Director, gives reasons and illustrates objectives.

Piam participates in CPhI 2019

Frankfurt 5-7 November: Piam is attending CPhI Worldwide for the fourth consecutive year. The event brings together over 45,000 senior pharmaceutical professionals, and 2,500 exhibitors from 150 countries...

PIAM takes part in the X National Congress SIMMESN 2019

Turin, 22-25 October 2019 PIAM takes part in the X National Congress SIMMESN (Italian Society for the Study of Inherited Metabolic Diseases and Newborn Screening), organizing a specific session, focused on slow-release protein substitutes of the Afenil line.

Piam participates in SSIEM 2019

PIAM, Italian leader in the dietary management of PKU and other IEM, is participating in SSIEM 2019, 2-6 September, Rotterdam. If you wish to contact us, please visit our stand E1.10

World PKU Day and Piam Iberia

Today, June 28 th 2019, PIAM celebrates the International Phenylketonuria (PKU) day announcing the opening of the new fully owned subsidiary PIAM Iberia with branch office in Madrid.

PIAM participates in CPhI Worldwide 2019

Frankfurt 5-7 November 2019: PIAM participates in CPhI Worldwide, visit us at stand 9.1 B32.

PIAM participates in Vitafoods Europe 2019

Geneva 7-9 May 2019: PIAM participates in Vitafoods Europe, visit us at our booth Q155.

Slow-release amino acid mixture

Slow-release micro tablets protein substitute